$RARE 3 SEC Filings

Filed On	Filing
10 Oct 2023	Form 3: Horn Howard, Chief Financial Officer No securities owned
02 May 2023	Form 3: Crombez Eric, EVP and Chief Medical Officer Holds 25,854 shares of Common Stock
22 Apr 2022	Form 3: Ray Amrit, Director No securities owned
30 Jun 2021	Form 3: Sanders Corazon (Corsee) D., Director No securities owned
30 Oct 2020	Form 3: Ultragenyx Pharmaceutical Inc., 10% owner · Solid Biosciences Inc Holds 7,825,797 shares of Common Stock
13 Oct 2020	Form 3: Dier Mardi, CFO & Executive Vice President No securities owned
25 Jun 2019	Form 3: Ultragenyx Pharmaceutical Inc., Director · Arcturus Therapeutics Holdings Inc Holds 2,400,000 shares of Common Stock
21 Jun 2019	Form 3: Harris Erik, EVP & Chief Commercial Officer Holds 9,861 shares of Common Stock
01 Feb 2019	Form 3: Suliman Shehnaaz, Director No securities owned
05 Oct 2018	Form 3: Hogenhuis Wladimir, Chief Operating Officer No securities owned
31 Jan 2018	Form 3: Bedrosian Camille L, EVP and Chief Medical Officer No securities owned
10 Apr 2017	Form 3: Dunsire Deborah, Director No securities owned
22 Jun 2016	Form 3: Parschauer Karah Herdman, EVP and General Counsel No securities owned
21 Mar 2016	Form 3: Ekman Lars, Director No securities owned
06 Aug 2015	Form 3: Dallas Jayson Donald Alexander, See Remarks No securities owned
20 Jul 2015	Form 3: Pinion John Richard, See Remarks No securities owned
07 May 2015	Form 3: Huang Dennis Karl, SVP & Chief TechOps Officer No securities owned
10 Apr 2015	Form 3: Welch Daniel G, Director No securities owned
24 Feb 2015	Form 3: Narachi Michael, Director No securities owned
21 Aug 2014	Form 3: Agarwal Sunil, Chief Medical Officer No securities owned

Comments